Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Galectin Therapeutic (NQ: GALT)
4.976 USD  -0.014 (-0.29%)
Streaming Delayed Price  /  Updated: 11:26 AM EDT, Oct 15, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 88,623
Open 5.000
Bid (Size) 4.960 (14)
Ask (Size) 4.990 (3)
Prev. Close 4.990
Today's Range 4.850 - 5.020
52wk Range 1.280 - 9.490
Shares Outstanding 37,740,647
Dividend Yield N/A
Performance
YTD
+28.90%
+28.90%
1 Month
-8.20%
-8.20%
3 Month
-17.89%
-17.89%
6 Month
+38.98%
+38.98%
1 Year
+115.39%
+115.39%
Top News
More News
Galectin Therapeutics to Participate in The ROTH Capital Battle of the NASH Thrones Investment Conference
Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today announced that management will participate in the upcoming ROTH Capital Battle of... Read More
from GlobeNewswire News Releases
Galectin Therapeutics to Present at The ROTH Capital Battle of the NASH Thrones Investment Conference
Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today announced that management will participate in the upcoming ROTH Capital Battle of... Read More
from GlobeNewswire News Releases
More News
Read More
Market Trends Toward New Normal in Altra Industrial Motion, IDEXX Laboratories, BioTelemetry, Galectin Therapeutics, NETGEAR, and Merck & Co. — Emerging Consolidated Expectations, Analyst Ratings
from GlobeNewswire News Releases
Galectin Therapeutics, Inc. Announces Positive Preliminary Results from Phase 1b Clinical Trial of GR-MD-02 and KEYTRUDA® in Advanced Melanoma and Expansion of the Trial
from GlobeNewswire News Releases
Galectin Therapeutics to Present at H.C. Wainwright 20th Annual Global Investment Conference
from GlobeNewswire News Releases
First Week of January 2021 Options Trading For Galectin Therapeutics (GALT)
category Stocks
from Market News Video
52 Biggest Movers From Friday
category BPTH , NTLA , HYRE , and 64 more.
from Benzinga
40 Stocks Moving In Friday's Mid-Day Session
category MTL , Mid/Day Gainers , DTEA , and 49 more.
from Benzinga
56 Biggest Movers From Yesterday
category Movers , AFMD , CLRB , and 65 more.
from Benzinga
28 Stocks Moving In Monday's Pre-Market Session
category SIR , IBCP , Market News , and 40 more.
from Benzinga
The Week Ahead In Biotech (Sept. 16-22): Conferences, PDUFA Dates, Clinical Trial Results And IPOs
category RARX , NITE , CTIC , and 32 more.
from Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.